Cognitive Health Startup Ivory raises fresh capital to strengthen deep tech offerings
The company plans to strengthen its product and clinical capabilities with this new fund raise
Rahul Krishnan and Issac John, Co-founders, Ivory
Ivory, a brain health platform focused on early cognitive screening, has raised $1M in fresh funding, onboarding new investors to deepen its product, clinical, and IP capabilities.
The round saw participation from Draper Associates, a global venture capital firm with a strong focus on biotech and healthtech, along with SAGE Venture Fund, an AIF fund launched by Ministry of Social Justice and Empowerment (MoSJE) (selection partners for Startups) and managed by IFCI Venture, a subsidiary of IFCI Limited and Small Industries Development Bank of India (SIDBI). The investment reflects growing institutional interest in preventive health platforms that are building for scale and real-world impact.
Ivory is addressing a critical gap in India’s healthcare ecosystem by making cognitive screening accessible, trackable, and part of routine preventive care. While millions of Indians actively monitor physical health markers, cognitive health remains largely unmeasured, with a significant proportion of impairments going undiagnosed.
With this capital, the company plans to further strengthen its technology stack, expand clinical capabilities, and enhance its product offerings particularly in building scalable, evidence-based solutions that integrate seamlessly across both consumer and clinical workflows.
Rahul Krishnan, Co-founder & CPO, Ivory, said “Preventive healthcare in India is at an inflection point, but cognitive health has largely remained outside this shift. Our focus at Ivory is to make brain health measurable and actionable, much like other key health biomarkers. This round allows us to deepen our clinical and product capabilities, while continuing to build a scalable, digital-first layer for cognitive screening across both consumers and healthcare systems.”
Anish Babu, Managing Director, IFCI Venture, said “We are seeing strong momentum in startups building for preventive healthcare and large-scale health impact. Ivory is addressing a significant unmet need in cognitive health through a clinically grounded and technology-led approach. We are pleased to support their journey as they work towards making early cognitive screening more accessible and mainstream in India.”
Furthermore, this investment reflects broader institutional support for early-stage startups focused on public health impact, with organizations like IFCI Venture and initiatives supported by the Ministry of Social Justice and Empowerment playing an important role in enabling innovation in critical healthcare segments for Silver Economy in India.
The company has also been expanding its partnerships across the healthcare ecosystem. Most recently, Ivory collaborated with Metropolis Healthcare, a multinational chain of diagnostic labs, to launch the TruHealth Mind & Body package, an integrated preventive health offering that combines pathology diagnostics with neuroscience-based cognitive assessments.
This offering brings together physical and cognitive health into a single screening experience, enabling individuals to track key cognitive functions such as memory, attention, and executive function alongside traditional health markers, reflecting a more holistic approach to preventive care.
Ivory had made a successful appearance on Shark Tank India last year. Apart from this, Ivory has previously raised $1 million in a round co-led by IIM-A Ventures & Capital A. The company also counts 1Crowd, TDV Partners and Stanford Angels among its investors.
As part of its broader roadmap, Ivory continues to build towards making cognitive health a routine, trackable metric, bridging the gap between early detection and proactive intervention in India’s evolving preventive healthcare landscape.
Got a story that Healthcare Executive should dig into? Shoot it over to arunima.rajan@hosmac.com—no PR fluff, just solid leads.